9. Treatment of Amatoxin Poisoning-20 year retrospective analysis

756
Hepatoprotective Activity of Kutkin—The Iridoid
Glycoside Mixture of Picrorhiza kurrooa. Indian
J. Med. Res. 1988, 401–404.
389. Dwivedi, Y.; Rastogi, R.; Garg, N.K.; Dhawan, B.N.
Effects of Picroliv, the Active Principle of Picrorhiza
kurroa, on Biochemical Changes in Rat Liver Poisoned
by Amanita phalloides. Chung-kuo Yao Li Hsueh Pao
1992, 13 (3), 197–200.
390. Floersheim, G.L.; Bieri, A.; Koenig, R.; Pletscher, A.
Protection Against Amanita phalloides by the Iridoid
Glycoside Mixture of Picrorhiza kurroa (Kutkin).
Agents Actions 1990, 29 (3/4), 386–387.
391. Chen, N.; Bowles, M.R.; Pond, S.M. Polyclonal
Amanitin-Specific Antibodies: Production and Cytoprotective
Properties In Vitro. Biochem. Pharmacol. 1993,
46 (2), 327–329.
392. Faultstich, H.; Kirchner, K.; Derenzini, M. Strongly
Enhanced Toxicity of the Mushroom Toxin Alpha-
Amanitin by an Amatoxin-Specific Fab or Monoclonal
Antibody. Toxicon 1998, 26 (5), 491–499.
393. Tempé J.D.; Lutun, P.; Schneider, F.; Bilbault, P.;
Marcoux, L. Hépatites Aiguës Toxiques. Indications et
Résultats de la Transplantation Hépatique. XXXIème
Congrès de la Société de Toxicologie Clinique, Nancy,
France, Sept 16–17, 1993; Part I, 1–29.
394. Gubernatis, G.; Pichlmayr, R.; Kemnitz, J.; Gratz, K.
Auxiliary Partial Orthotopic Liver Transplantation
(APOLT) for Fulminant Hepatic Failure: First
Successful Case Report. World J. Surg. 1991, 15,
660–665.
395. Boudjema, K.; Siméoni, U.; Becmeur, F.; Schiffer, F.;
Odeh, M.; Chenard, M.P.; Bellocq, J.P.; Wolf, P.;
Gelsert, J.; Sauvage, P.; Cinquabre, J.; Jaeck, D.
Transplantation Hépatique Auxiliaire dans le Traitement
de l’Hépatite Fulminante chez l’Enfant: À Propos d’Une
Observation. Réa. Urg. 1993, 3, 316.
396. Moritz, M.J.; Jarrell, B.E.; Munoz, S.J.; Maddrey, W.C.
Regeneration of the Native Liver After Heterotopic
Liver Transplantation for Fulminant Hepatic Failure.
Transplantation 1992, 55 (4), 952–954.
397. Chenard-Neu, M.P.; Boudjema, K.; Bernuau, J.; Degott,
C.; Belghiti, J.; Cherqui, D.; Costes, V.; Domergue, J.;
Durand, F.; Ehrard, J.; De Hemptinne, B.; Gubernatis,
G.; Hadengue, A.; Kemnitz, J.; McCarthy, M.; Maschek,
H.; Mentha, G.; Oldhafer, K.; Portmann, B.; Praet, M.;
Ringers, J.; Rogiers, X.; Rubbia, L.; Schalm, S.; Ten
Kate, F.; Terpstra, O.; Van Hoek, B.; Williams, R.;
Zafrani, E.S.; Cinqualbre, J.; Wolf, P.; Jaeck, D.;
Bellocq, J.P. Auxiliary Liver Transplantation:
Regeneration of the Native Liver and Outcome in
30 Patients with Fulminant Hepatic Failure—A Multicenter
European Study. Hepatology 1996, 23,
1119–1127.
398. Duffy, T.J. Liver Transplantation for Victims of Amanita
Mushroom Poisoning. McIlvainea 1989, 9 (1), 4–5.
MARCEL DEKKER, INC. 270 MADISON AVENUE NEW YORK, NY 10016
©2002 Marcel Dekker, Inc. All rights reserved. This material may not be used or reproduced in any form without the express written permission of Marcel Dekker, Inc.
Enjalbert et al.
399. Frohburg, E.; Stölzel, U.; Lenz, K.; Schäfer, J.H.; Tung,
L.C.; Riecken, E.O. Prognostic Indicators in
Fulminant Hepatic Failure. Z. Gastroenterol. 1992, 30,
571–575.
400. Caraceni, P.; Van Thiel, D.H. Acute Liver Failure.
Lancet 1995, 345, 163–169.
401. Castells, A.; Salmeron, J.M.; Navasa, M.; Rimola, A.;
Salö, J.; Andreu, H.; Mas, A.; Rodès, J. Liver
Transplantation for Acute Liver Failure: Analysis of
Applicability. Gastroenterology 1993, 105, 532–538.
402. Chapman, R.W.; Forman, D.; Perto, R.; Smallwood, R.
Liver Transplantation for Acute Hepatic Failure? Lancet
1990, 335, 32–35.
403. Lake, J.R.; Sussman, N.L. Determining Prognosis in
Patients with Fulminant Hepatic Failure: When You
Absolutely Positively Have to Know the Answer.
Hepatology 1995, 21 (3), 879–881.
404. Jaeger, A.; Kopferschmitt, J.; Flesch, F.; Berton, C.;
Levenos, H.; Sauder, P. Liver Transplantation for
Amanita Poisoning. Congress of Anti-Poisons Centre,
Istambul, Turkey, May 24–27, 1992; 103.
405. O’Grady, J.G.; Alexander, G.J.M.; Hayllar, K.M.;
Williams, R. Early Indicators of Prognosis in
Fulminant Hepatic Failure. Gastroenterology 1989, 97,
439–445.
406. Shakil, A.O.; Kramer, D.; Mazariegos, G.V.; Fung, J.J.;
Rakela, J. Acute Liver Failure: Clinical Features,
Outcome Analysis, and Applicability of Prognostic
Criteria. Liver Transplant. 2000, 6 (2), 163–169.
407. Bernuau, J.; Samuel, D.; Durand, F.; Saliba, F.;
Bourlière, M.; Adam, R.; Gugenheim, J.; Castaing, D.;
Bismuth, H.; Rueff, B.; Erfinger, S.; Benhamou, J.P.
Criteria for Emergency Liver Transplantation in Patients
with Acute Viral Hepatitis and Factor V (FV) Below
50% of Normal: A Prospective Study. Hepatology 1991,
14, 49A.
408. Bismuth, H.; Samuel, D.; Gugenheim, J.; Castaing, D.;
Bernuau, J.; Rueff, B.; Benhamou, J.P. Emergency Liver
Transplantation for Fulminant Hepatitis. Ann. Intern.
Med. 1987, 107, 337–341.
409. Bismuth, H.; Samuel, D.; Castaing, D.; Adam, R.;
Saliba, F.; Johann, M.; Azoulay, D.; Ducot, B.; Chiche,
L. Orthotopic Liver Transplantation in Fulminant and
Subfulminant Hepatitis. The Paul Brousse Experience.
Ann. Surg. 1995, 222 (2), 109–119.
410. Pereira, L.M.M.B.; Langley, P.G.; Hayllar, K.M.;
Tredger, J.M.; Williams, R. Coagulation Factor V and
VIII/V Ratio as Predictors of Outcome in Paracetamol
Induced Fulminant Hepatic Failure: Relation to Other
Prognostic Indicators. Gut 1992, 33, 98–102.
411. Lee, W.M.; Galbraith, R.M.; Watt, G.H.; Hughes, R.D.;
McIntire, D.D.; Hoffman, B.J.; Williams, R. Predicting
Survival in Fulminant Hepatic Failure Using Serum Gc
Protein Concentrations. Hepatology 1995, 21 (1),
101–105.